Adverse events464

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 464

Type	Event	Organ system	Group	Affected	At risk
other	Anaemia	Blood and lymphatic system disorders	Lutathera® Plus Octreotide LAR 30 mg	27	147
other	Anaemia	Blood and lymphatic system disorders	Octreotide LAR 60 mg (Control Arm)	4	73
other	Anaemia	Blood and lymphatic system disorders	Crossover Lutathera	2	29
other	Anaemia	Blood and lymphatic system disorders	Re-Treatment Lutathera	0	8
other	Lymphopenia	Blood and lymphatic system disorders	Lutathera® Plus Octreotide LAR 30 mg	9	147
other	Lymphopenia	Blood and lymphatic system disorders	Octreotide LAR 60 mg (Control Arm)	0	73
other	Lymphopenia	Blood and lymphatic system disorders	Crossover Lutathera	1	29
other	Lymphopenia	Blood and lymphatic system disorders	Re-Treatment Lutathera	0	8
other	Neutropenia	Blood and lymphatic system disorders	Lutathera® Plus Octreotide LAR 30 mg	4	147
other	Neutropenia	Blood and lymphatic system disorders	Octreotide LAR 60 mg (Control Arm)	0	73
other	Neutropenia	Blood and lymphatic system disorders	Crossover Lutathera	0	29
other	Neutropenia	Blood and lymphatic system disorders	Re-Treatment Lutathera	1	8
other	Thrombocytopenia	Blood and lymphatic system disorders	Lutathera® Plus Octreotide LAR 30 mg	12	147
other	Thrombocytopenia	Blood and lymphatic system disorders	Octreotide LAR 60 mg (Control Arm)	0	73
other	Thrombocytopenia	Blood and lymphatic system disorders	Crossover Lutathera	2	29
other	Thrombocytopenia	Blood and lymphatic system disorders	Re-Treatment Lutathera	0	8
other	Abdominal discomfort	Gastrointestinal disorders	Lutathera® Plus Octreotide LAR 30 mg	2	147
other	Abdominal discomfort	Gastrointestinal disorders	Octreotide LAR 60 mg (Control Arm)	2	73
other	Abdominal discomfort	Gastrointestinal disorders	Crossover Lutathera	0	29
other	Abdominal discomfort	Gastrointestinal disorders	Re-Treatment Lutathera	1	8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03972488/events

API reference For AI assistants

Adverse events464

Sources 3

Read this list from software.